Slideshow

New FDA Warning on Clozapine

Author(s):

Chris Aiken, MD

This adverse reaction to clozapine causes more fatalities than neutropenia. Here’s how to prevent it.

Related Videos
journey
Related Content
bipolar disorder
September 20th 2024

To Be or Not to Be? Understanding False Positives in Bipolar Diagnosis

Autumn Roque, DNP, APRN, PMHNP-BC Michael Asbach, DMSc, PA-C, Psych-CAQ
Blue Light, Depression, and Bipolar Disorder
August 4th 2021

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
A poster presented at the 2024 ASCP Annual Meeting discussed the results of a study analyzing the treatment’s safety and efficacy in this patient population.
May 30th 2024

Evaluating the Efficacy of Lumateperone for MDD and Bipolar Depression With Mixed Features

Erin O'Brien
Four Myths About Lamotrigine
August 3rd 2021

Four Myths About Lamotrigine

Chris Aiken, MD Kellie Newsome, PMH-NP
An expert discusses the role of cognition in bipolar disorder and the potential of modafinil as a treatment for it at the 2024 ASCP Annual Meeting.
May 29th 2024

Efficacy of Modafinil for Treatment of Neurocognitive Impairment in Bipolar Disorder

Erin O'Brien
An expert shares some lessons learned from prior research on the treatment and suggestions for a way forward at the 2024 ASCP Annual Meeting.
May 28th 2024

Revisiting Modafinil/Armodafinil for the Treatment of Bipolar Disorder

Erin O'Brien
© 2024 MJH Life Sciences

All rights reserved.